Dana Investment Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Dana Investment Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,590	Closed	-$203K	–	546
2025 Q1	$203K	Sell	1,590 -935	-37%	-$127K	0.01%	530
2024 Q4	$334K	Hold	2,525	–	–	0.01%	492
2024 Q3	$368K	Buy	+2,525	New	+$365K	0.01%	480
2023 Q1	–	Sell	-1,639	Closed	-$215K	–	406
2022 Q4	$215K	Buy	+1,639	New	+$212K	0.01%	383
2018 Q1	–	Sell	-2,058	Closed	-$220K	–	277
2017 Q4	$220K	Hold	2,058	–	–	0.01%	262
2017 Q3	$229K	Sell	2,058 -165	-7%	-$17.6K	0.01%	253
2017 Q2	$230K	Hold	2,223	–	–	0.01%	262
2017 Q1	$217K	Buy	+2,223	New	+$213K	0.01%	270
2016 Q4	–	Sell	-7,218	Closed	-$696K	–	295
2016 Q3	$696K	Buy	7,218 +2,322	+47%	+$221K	0.03%	219
2016 Q2	$420K	Hold	4,896	–	–	0.02%	227
2016 Q1	$426K	Buy	4,896 +3,240	+196%	+$290K	0.02%	223
2015 Q4	$552K	Sell	1,656 -2,235	-57%	-$243K	0.03%	219
2015 Q3	$393K	Buy	+3,891	New	+$467K	0.02%	226

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Dana Investment Advisors's IBB Position: Q2 2025 in Review

Dana Investment Advisors sold out of iShares Biotechnology ETF (IBB) in Q2 2025, closing a stake of 1,590 shares — an estimated $203K sold.

Dana Investment Advisors first reported a position in IBB in Q3 2015 and held it in 13 quarters. The position peaked at $696K in Q3 2016. 797 funds tracked by Wall St. Rank hold IBB as of Q2 2025.

Dana Investment Advisors reported no remaining iShares Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
Dana Investment Advisors sold 1,590 iShares Biotechnology ETF shares in Q2 2025, an estimated $203K.
Dana Investment Advisors first reported a position in iShares Biotechnology ETF in Q3 2015 and held it in 13 quarters.
Dana Investment Advisors's iShares Biotechnology ETF position peaked at $696K in Q3 2016.
797 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2025.

Based on Dana Investment Advisors's 13F filing for Q2 2025, filed 13 Aug 2025.